Retinol serums sold as cosmetics in the US do not require FDA pre-market approval, but they do need to comply with FDA cosmetic labeling and safety regulations, and the distinction between a cosmetic claim and a drug claim is the most important compliance line to understand. If your serum is marketed purely for appearance, such as 'improves the look of fine lines' or 'smooths skin texture,' it's regulated as a cosmetic. If you market it with therapeutic claims, such as 'treats acne' or 'reduces wrinkles by altering skin structure,' the FDA can classify it as an over-the-counter drug, which triggers a much stricter regulatory pathway including FDA drug registration and different manufacturing standards.
Under the Modernization of Cosmetics Regulation Act (MoCRA), which took fuller effect in 2023-2024, cosmetic manufacturers and brand owners now face additional requirements: facility registration with the FDA, product listing, adverse event reporting, and a requirement to have safety substantiation on file for each product. This applies to your manufacturer's facility as well as, in some cases, the brand owner, so it's worth confirming your manufacturer is MoCRA-compliant with current facility registration before signing a production agreement.
Labeling requirements are specific and commonly get first-timers into trouble. Your ingredient list must be in proper INCI (International Nomenclature of Cosmetic Ingredients) order by concentration, your net weight must be displayed correctly, and any claims must be substantiated by data you can produce if the FDA or a competitor challenges them. Claims like 'clinically proven' or 'dermatologist tested' require you to actually have that testing on file, not just a manufacturer's general assurance.
Retinol specifically has no FDA-mandated maximum concentration for cosmetic use in the US (unlike some EU restrictions, discussed below), but responsible manufacturers generally cap cosmetic-category retinol serums well below prescription-strength retinoid levels to stay clearly within cosmetic rather than drug territory.
If you plan to sell internationally, especially into the EU, be aware that EU cosmetics regulation has specific concentration limits on retinol (0.3% in body products, 0.05% in face products under recent restrictions) that don't exist in the same form under US rules, so a formula compliant for US sale may need reformulation for EU market entry.
The common mistake is assuming your manufacturer automatically handles all compliance on your behalf. Manufacturing compliance (facility registration, GMP practices) and marketing/labeling compliance (claims substantiation, INCI listing accuracy) are often split responsibilities between manufacturer and brand owner, and founders should clarify in writing who owns which piece before production begins.
Within AJ Cosmo Labs, manufacturer profiles indicate compliance certifications and facility registrations, giving you a starting point for due diligence before you download the app and begin messaging suppliers about your specific formula and market.
Ingredients in this answer: Retinol
Read the full guide on Private Label Retinol Serum Manufacturer for Sensitive Skin →